Teladoc Health Inc (TDOC) concluded trading on Wednesday at a closing price of $9.88, with 5.86 million shares of worth about $57.92 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 7.51% during that period and on January 22, 2025 the price saw a gain of about 4.00%. Currently the company’s common shares owned by public are about 171.94M shares, out of which, 168.52M shares are available for trading.
Stock saw a price change of 5.56% in past 5 days and over the past one month there was a price change of 4.44%. Year-to-date (YTD), TDOC shares are showing a performance of 8.69% which decreased to -51.19% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $6.76 but also hit the highest price of $21.74 during that period. The average intraday trading volume for Teladoc Health Inc shares is 5.29 million. The stock is currently trading 4.08% above its 20-day simple moving average (SMA20), while that difference is down -0.72% for SMA50 and it goes to -0.34% lower than SMA200.
Teladoc Health Inc (NYSE: TDOC) currently have 171.94M outstanding shares and institutions hold larger chunk of about 72.92% of that.
The stock has a current market capitalization of $1.70B and its 3Y-monthly beta is at 1.04. It has posted earnings per share of -$5.78 in the same period. It has Quick Ratio of 1.65 while making debt-to-equity ratio of 1.05. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for TDOC, volatility over the week remained 5.70% while standing at 5.94% over the month.
Analysts are in expectations that Teladoc Health Inc (TDOC) stock would likely to be making an EPS of -0.27 in the current quarter, while forecast for next quarter EPS is -0.37 and it is -1.03 for next year. For the current quarter EPS, analysts have given the company a lowest target -0.3 which is -0.22 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -0.14 in the same quarter a year ago. Stock’s fiscal year EPS is expected to drop by -334.37% while it is estimated to increase by 84.72% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Goldman on November 15, 2024 offering a Buy rating for the stock and assigned a target price of $14 to it. Coverage by Jefferies stated Teladoc Health Inc (TDOC) stock as a Hold in their note to investors on September 17, 2024, suggesting a price target of $10 for the stock. On February 29, 2024, Cantor Fitzgerald Initiated their recommendations, while on February 26, 2024, Leerink Partners Initiated their ratings for the stock with a price target of $17. Stock get a Neutral rating from DA Davidson on January 17, 2024.
